Sun pharma ranbaxy merger sun pharmaceutical industries ltd. Read more about sun pharma, ranbaxy gain ahead of merger on business standard. Sun pharma ranbaxy nishith desai associates nda is a research based international law firm with offices in mumbai, bangalore, silicon valley, singapore, new delhi, munich. Pharmacy sector the pharmaceutical industry develops, produces, and markets drugs or pharmaceuticals licensed for use as medications. The boards of indias two leading pharmaceutical companies, sun pharmaceuticals and ranbaxy laboratories, announced their merger in april 2014. The merger creates the fifth largest global specialty generic pharma company in the world. But the merger came with its fair share of challenges for sun pharma. Talks about difference between mergers and acquisition, different types of mergers and finally the acquisition of ranbaxy by sun pharma.
The big news of the week was about a mega merger of two of indias largest pharma companies, sun pharma and ranbaxy. Mergers, acquisitions, sun pharma, ranbaxy, financial ratios. Daiichi files a petition before the andhra pradesh high court requesting it to vacate the status quo. Whether the merger is positive for sun original shareholders in the long run.
Over the past 5 days, ranbaxy shares jumped 22%, while sun pharma. Mckinsey hired to assist merger of sun, ranbaxy business. Apr 07, 2014 sun pharma, a large indian drug maker, has announced acquisition of ranbaxy laboratories, another indian pharmaceutical company. Three of ranbaxy s plants in india, supplying products to the us, are still banned by the us food and drug administration fda. Sun pharma, ranbaxy gain ahead of merger business standard news. The merger wont have too many cultural and integration issues since both companies are indian.
Read expert opinions, top news, insights and trends on the economic times. Read expert opinions, top news, insights and trends on. At 1107 hours, sun pharma and ranbaxy laboratories were up 3% each at rs 1,052 and rs 837 respectively. Sun pharma ends merger deal with ranbaxy biopharma asia. Sun pharma ranbaxy ppt 1 free download as powerpoint presentation. The sun pharmaceuticalranbaxy combine, indias largest drugmaker, now has a toplevel team in place. Mar 25, 2015 through this merger completion, ranbaxy will be delisted from the indian stock exchanges, with ranbaxy shareholders receiving 0. The exchange ratio represents an implied value of rs 457 for each ranbaxy share, a premium of 18% to ranbaxy s 30day volumeweighted average share price and a premium of 24. Read more about mckinsey hired to assist merger of sun, ranbaxy on business standard. The deal has reaped the benefit in the market price also as sun pharma market price after the date of announcement of merger with ranbaxy till the record the date of merger has touch a new high to inr 1200 per share i. Taking forward its acquisition of ranbaxy laboratories, sun pharma has put in place a team of top executives, including dilip shanghvis son aalok shanghvi, to. The exchange ratio represents an implied value of rs 457 for each ranbaxy share, a premium of 18% to ranbaxys 30day volumeweighted average share price and a premium of 24. Sun pharma executives bag top slots in company after.
Cci nod for sun pharmaranbaxy merger with caveats the. Competition commission of india combination registration no. The mistakes daiichi sankyo made in the ranbaxy deal. Ranbaxy will be merged with sun pharma by means of a share swap. Ranbaxy pdf file each ranbaxy share, a premium of 18 to ranbaxys 30day.
The competition commission of india has approved the sun pharma ranbaxy merger with some caveats. Ranbaxy will merge into sun pharma and the shareholders of ranbaxy will. In 2008, japanese pharmaceutical company daiichi sankyo acquired a controlling share in ranbaxy and in 2014, sun pharma acquired. Ranbaxysun pharma merger deal may close by 2014 end. Ranbaxys journey as a company to end after merger with sun. Under these agreements, ranbaxy will merge into sun pharma and the shareholders of ranbaxy will receive 0. Daily reporting 09042020 sun pharmaceutical industries. Ownership of ranbaxy changed twice over the course of its history. Regulatory action against ranbaxy these facilities are now owned by sun pharmaceutical. We specialize in strategic legal, regulatory and tax advice coupled with industry expertise in an integrated manner. Sunpharma and ranbaxy merge in 2014 to create indias largest and the worlds fifth largest pharma company. The company have received approval from the competition commission of india, subject to certain product divestments and other terms. Honeymoon over, now to make it work, live mint, june 02, 2015.
Sun pharma and ranbaxy have a combined field staff of about 9,000. Shweta mahadik 110 surendra saroj 111 sushmitha raikar 1 swapnil rajwade 115 trinette dmello 117 valen miranda 119 introduction sunpharmaceuticals sunpharmaceuticals was established in 1983 in vapi with five products to analyze sickness. Sunpharma and ranbaxy merge in 2014 to create indias largest and the worlds. Sun pharma completes ranbaxy merger deal, ranbaxy shares to be delisted. Why is sun pharmaceutical in trouble after the ranbaxy merging. The merger has fortified sun pharma s position as the worlds fifth largest specialty generic pharmaceutical. Transcript sun pharma ranbaxy merger conference call. We specialize in strategic legal, regulatory and tax advice coupled with industry expertise in. All medicines for ranbaxy uk limited a sun pharmaceutical. What was sun pharmas rationale for acquiring ranbaxy. Mar 25, 2015 shares in sun pharmaceuticals industries and ranbaxy laboratories gained on wednesday after sun pharma said that all the requisite approvals have been received for the merger of ranbaxy into sun. Experts say ranbaxy acquisition positive for sun pharma. The merger will create the worlds fifth largest specialtygeneric pharmaceutical company and the largest player in the indian pharma market.
A merger in which sun pharma is the surviving company and ranbaxy is the company to be absorbed. Dec 10, 2014 sun pharmaceutical industries ltd has moved closer to finalizing its acquisition of ranbaxy laboratories. Ebidta margin at 32% industry average 19% and net margin at 20% industry average 12%. The dynamics of major indian takeovers their causes. The proposed combination relates to the merger of ranbaxy into sun pharma pursuant to the scheme of arrangement approved by their respective board of. Announcement regarding merger between sun pharma and daiichi. Sun pharma ranbaxy merger conference call transcript 08.
For whatever it is worth, i went to their web site and got redirected to that of sun pharma. C201405170 page 3 of 56 fair competition for greater good proposed combination 7. Why the fall in shares may just be a blip and what the. The merger, which is all stock, will give ranbaxy shareholders 0. A case study of sun pharmaceuticals and ranbaxy laboratories. Lupin, nicolas piramal, aurobindo pharma, cadila pharmaceuticals, sun pharma, wockhardt ltd. The merger will see sun pharma s revenue jump by a healthy 40% but its operating profit will rise by a meagre 7. Sun pharma and ranbaxy to merge, create giant pharma co. Sun pharmaceuticals acquisition of ranbaxy business.
Information and announcements about this can be found on this page. Ftc allows ranbaxysun pharma merger divestiture order 2015. The integration, planned by sun pharma over many months, will focus on supporting strong growth. Shareholders of ranbaxy are bound to be concerned about the tax implications, if any, arising on the shareswap in the ranbaxy sun pharma deal. Sun pharma in a filing to bse said that ranbaxy shareholders will get 8 shares of sun pharma for every 10 stocks they hold.
Sun pharma announces closure of merger deal with ranbaxy beginning today, integration to focus on enhancing productivity. As of march 2014, the promoter holding in sun pharma and ranbaxy stands at 63. Oct 23, 2015 the merger with ranbaxy by sun pharmaceuticals has given the company scale to move up the food chain in the industry but has. Ranbaxy delists on completion of merger with sun pharma.
Sun pharmaranbaxy deal comes under cci scanner business. Extensive product basket largely branded business with minimal overlap. Sun pharma buys ranbaxy to create worlds fifth largest specialty generic pharma company. To study the need of sun pharma and ranbaxy merger. This case attempts to enumerate a step by step procedure for calculating cumulative abnormal return car for the case of sun pharma ranbaxy merger. It is an indian multinational pharmaceutical company headquatered in mumbai. Merger with ranbaxy laboratories poses challenges for sun. Sun pharma executives bag top slots in company after ranbaxy.
Merger acquisition sun pharma ranbaxy free download as powerpoint presentation. Jersey requesting that ranbaxy produce certain documents relating to. On pro forma basis for 12 months ended december 2014, sun pharmas gross margin stands at 76% industry average 62%. Developing complex products and exploiting first to file opportunities. Sun pharma to delist ranbaxy after merger huffpost india. Sun pharma completes ranbaxy merger deal, ranbaxy shares to. Acme plaza, andheri kurla road, andheri east, mumbai 400 059. Us fda approval, including many highvalue ftf first to file opportunities. Hello fellow wikipedians, i have just modified 4 external links on ranbaxy laboratories. Acquisition, post merger, integration, pharmaceutical sector, synergies. Why is sun pharmaceutical in trouble after the ranbaxy. It was a well thought out decision by the management of sun pharmaceutical industries.
The merger with ranbaxy laboratorie s was intended to help indias largest drug maker. Press release for closure of sun ranbaxy merger sun pharma. Sun pharma announces closure of merger deal with ranbaxy. Apr 08, 2014 sunpharma and ranbaxy merge in 2014 to create indias largest and the worlds fifth largest pharma company. The sun pharmaceutical ranbaxy combine, indias largest drugmaker, now has a toplevel team in place. Car is an academic way of analyzing merger performance based on stock market returns of both acquirer and. Thus, the merger will have a negative effect on its performance in the near term. The transaction will combine sun pharmas proven complex product. Announcement regarding merger between sun pharma and. Ranbaxy merger showing sharp cons as well as pros for sun pharma. In one stroke sun pharmaceuticals has doubled its size in a cashless transaction by acquiring one of indias largest pharmaceutical company ranbaxy.
Ranbaxy will merge into sun pharma and the shareholders of ranbaxy will receive 0. The sun pharma merger with ranbaxy will blend the complementary market. According to the conditions imposed by the commission, the merged entity will have to divest seven. No tax impact on shareholders after sunranbaxy merger. As one of the top pharmaceuticals in india and worldwide, ranbaxy laboratories limited. On april 06, 2014, indiabased pharmaceutical companies, sun pharmaceutical industries sun pharma and ranbaxy laboratories limited ranbaxy, entered into an agreement under which sun pharma would acquire 100% of ranbaxy in an all stocktransaction. Once the merger is completed, many of the sales personnel will end up covering the same doctors, especially in the specialty. In a communique addressed to his colleagues, sun pharma founder and md dilip. In some of the countries it was seen as innovator company in line with pfizer, merck etc. After the acquisition, sun s promoters stake will come down to 54. Shares of sun pharma witnessed massive selling pressure, plunging over 16 percent after the drug major said it expects to take a hit on profit for the fiscal 201516 mainly due to integration process with ranbaxy.
769 423 1242 19 1536 473 871 176 271 1346 1064 854 1514 758 295 142 752 928 829 183 114 705 789 1279 944 367 852 404 1322 22 432 315 791 250 1375 185 524 1345 153 955